Two case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusion
dc.contributor.author | Reyland, L | |
dc.contributor.author | Dwight, M | |
dc.contributor.author | Bullock, T | |
dc.contributor.author | Latham, T | |
dc.contributor.author | Lord, K | |
dc.contributor.author | Wardle, A | |
dc.contributor.author | Palmer, D | |
dc.contributor.author | Eggington, J | |
dc.contributor.author | Callaghan, T | |
dc.contributor.author | Seals, Deborah | |
dc.contributor.author | Kulkarni, Samar | |
dc.date.accessioned | 2020-01-29T15:17:55Z | |
dc.date.available | 2020-01-29T15:17:55Z | |
dc.date.issued | 2020 | en |
dc.identifier.citation | Reyland L, Dwight M, Bullock T, Latham T, Lord K, Wardle A, et al. Two case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusion. Transfus Med. 2020. | en |
dc.identifier.pmid | 31914482 | en |
dc.identifier.doi | 10.1111/tme.12664 | en |
dc.identifier.uri | http://hdl.handle.net/10541/622709 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1111/tme.12664 | en |
dc.title | Two case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusion | en |
dc.type | Article | en |
dc.contributor.department | NHS Blood and Transplant-Filton, Red Cell Immunohaematology Laboratory, Bristol, UK | en |
dc.identifier.journal | Transfusion Medicine | en |
dc.description.note | en] |